Displaying drugs 176 - 200 of 12628 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| WIN-54954 | 383.269 C18H20Cl2N2O3 |  | WIN-54954 is a broad-spectrum antipicornavirus drug. | Not Available |
| WIN 55212-2 | 426.516 C27H26N2O3 |  | WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical structure. It... | Agents producing tachycardia |
| Willardiine | 199.166 C7H9N3O4 |  | Willardiine is a compound isolated from seeds of Acacia willariana. | Amino Acids / Amino Acids, Peptides, and Proteins / Pyrimidines / Pyrimidinones |
| WAY-151693 | 427.474 C21H21N3O5S |  | Not Available | Amides / Amines / Hydroxy Acids / Hydroxylamines / Sulfones / Sulfur Compounds |
| Water | 18.0153 H2O |  | A naturally-occurring element used as an ingredient and vehicle in various pharmaceutical preparations of water. | Diluents / EENT Drugs, Miscellaneous / Irrigating Solutions / Other Miscellaneous Therapeutic Agents / Oxygen Compounds |
| Warfarin | 308.3279 C19H16O4 |  | A vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction. | 4-Hydroxycoumarins / Anticoagulants / Rodenticides / Vitamin K Antagonists |
| VX-765 | Not Available |  | Investigated for use/treatment in inflammatory disorders (unspecified) and psoriasis and psoriatic disorders. | Acids, Carbocyclic / Amino Acids, Peptides, and Proteins / Aminobenzoates / Benzene Derivatives / Benzoates / Oligopeptides / Peptides |
| VX-702 | 404.325 C19H12F4N4O2 |  | Investigated for use/treatment in coronary artery disease, inflammatory disorders (unspecified), and rheumatoid arthritis. | Amides / Benzene Derivatives |
| VX-148 | Not Available |  | Investigated for use/treatment in autoimmune diseases, psoriasis and psoriatic disorders, and viral infection. | Amides / Benzene Derivatives |
| VTP-27999 | 525.081 C26H41ClN4O5 |  | VTP-27999 has been used in trials studying the basic science of Renal Function. | Renin Inhibitors |
| VTP-201227 | Not Available |  | Investigated for use/treatment in psoriasis and psoriatic disorders. | Not Available |
| VTP-194204 | 352.518 C24H32O2 |  | Nrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer. | Ligands |
| VT-1598 | 584.535 C31H20F4N6O2 |  | Not Available | Not Available |
| VSF-173 | Not Available |  | Investigated for use/treatment in sleep disorders. | Not Available |
| VS-5584 | 354.418 C17H22N8O |  | VS-5584 has been used in trials studying the treatment of Lymphoma, Metastatic Cancer, and Non Hematologic Cancers. | Heterocyclic Compounds, Fused-Ring / Oxazines |
| VS-4718 | 501.51 C25H26F3N5O3 |  | VS-4718 is under investigation in clinical trial NCT02215629 (Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia). | Focal Adhesion Protein-Tyrosine Kinases, antagonists & inhibitors |
| VPO-227 | 548.349 C26H18BrN3O6 |  | Not Annotated | Not Annotated |
| VP025 | Not Available |  | Investigated for use/treatment in alzheimer's disease and inflammatory disorders (unspecified). | Not Available |
| VP-14637 | 510.518 C25H22N10O3 |  | MDT-637 has been investigated for the treatment of Drug Safety. | Benzene Derivatives / Hydrazines |
| Voxtalisib | 270.296 C13H14N6O |  | Voxtalisib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Breast Cancer, among others. | Phosphatidylinositol 3-Kinases, antagonists & inhibitors |
| Voxilaprevir | 868.94 C40H52F4N6O9S |  | A nonstructural protein 3 and 4a protease inhibitor used to treat Hepatitis C infections. | Antivirals for treatment of HCV infections |
| Voxelotor | 337.379 C19H19N3O3 |  | A drug used to inhibit the polymerization of hemoglobin S, preventing the painful and sometimes lethal vaso-occlusive crises associated with sickle cell disease. | Hematologic Agents |
| Vosaroxin | 401.44 C18H19N5O4S |  | Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute. | Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Heterocyclic Compounds, Fused-Ring / Sulfur Compounds |
| Voruciclib | 469.84 C22H19ClF3NO5 |  | Voruciclib is under investigation in clinical trial NCT03547115 (A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML). | Antineoplastic Agents / Protein Kinase Inhibitors |
| Vortioxetine | 298.45 C18H22N2S |  | A serotonin modulating antidepressant indicated for the treatment of major depressive disorder (MDD). | Agents that produce hypertension |
Displaying drugs 176 - 200 of 12628 in total